Impact of anti-PDGFRα antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells.

[1]  D. MacManus,et al.  Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study , 2021, The Lancet Neurology.

[2]  K. Landfester,et al.  The conjugation strategy affects antibody orientation and targeting properties of nanocarriers. , 2021, Nanoscale.

[3]  G. Bastiat,et al.  Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules , 2021, Pharmaceutical Research.

[4]  A. Rae-Grant,et al.  Diagnosis and Treatment of Multiple Sclerosis: A Review. , 2021, JAMA.

[5]  P. Saulnier,et al.  Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro , 2020, Neurochemical Research.

[6]  C. Stadelmann,et al.  Remyelination in multiple sclerosis: from basic science to clinical translation , 2020, The Lancet Neurology.

[7]  G. Bijelic,et al.  MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles , 2020, Pharmaceutics.

[8]  Nicholas C. Fitzkee,et al.  Using NMR Spectroscopy To Measure Protein Binding Capacity on Gold Nanoparticles. , 2020, Journal of chemical education.

[9]  K. Landfester,et al.  A bio-orthogonal functionalization strategy for site-specific coupling of antibodies on vesicle surfaces after self-assembly , 2020, Polymer Chemistry.

[10]  A. della Puppa,et al.  Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules , 2019, Journal of Nanobiotechnology.

[11]  H. Hartung,et al.  An unmet clinical need: roads to remyelination in MS , 2019, Neurological Research and Practice.

[12]  N. Okada,et al.  Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel , 2019, International journal of molecular sciences.

[13]  S. Carradori,et al.  Influence of Ellagitannins Extracted by Pomegranate Fruit on Disulfide Isomerase PDIA3 Activity , 2019, Nutrients.

[14]  C. van Nostrum,et al.  Insights into maleimide‐thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Patrice D Cani,et al.  Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells. , 2018, Molecular pharmaceutics.

[16]  R. Franklin,et al.  Regenerating CNS myelin — from mechanisms to experimental medicines , 2017, Nature Reviews Neuroscience.

[17]  Ping Li,et al.  Expression of NG2 and platelet-derived growth factor receptor alpha in the developing neonatal rat brain , 2017, Neural regeneration research.

[18]  Alaaldin M. Alkilany,et al.  Cellular uptake of nanoparticles: journey inside the cell. , 2017, Chemical Society reviews.

[19]  J. Benoit,et al.  Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  V. Préat,et al.  NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[21]  P. Saulnier,et al.  Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules. , 2016, International journal of pharmaceutics.

[22]  A. Haddadi,et al.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles , 2015, International journal of nanomedicine.

[23]  B. Charleston,et al.  Assessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibody. , 2015, Vaccine.

[24]  Manuel A. Friese,et al.  Immunopathology of multiple sclerosis , 2015, Nature Reviews Immunology.

[25]  F. V. van Delft,et al.  Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates. , 2015, Bioconjugate chemistry.

[26]  J. Benoit,et al.  Tumour targeting of lipid nanocapsules grafted with cRGD peptides. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  J. Benoit,et al.  Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide , 2014, International journal of nanomedicine.

[28]  Alexander Jesacher,et al.  A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[30]  A. Vessières,et al.  Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  J. Hubbell,et al.  Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages , 2012, International journal of nanomedicine.

[32]  J. Barbet,et al.  Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery , 2011, Journal of drug delivery.

[33]  J. Benoit,et al.  Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. , 2010, International journal of pharmaceutics.

[34]  Igor L. Medintz,et al.  Preparation of stable maleimide-functionalized au nanoparticles and their use in counting surface ligands. , 2010, Small.

[35]  J. Benoit,et al.  Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting. , 2009, International journal of pharmaceutics.

[36]  I. Pyykkö,et al.  Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[37]  J. Benoit,et al.  Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. , 2007, Biomaterials.

[38]  K. Landfester,et al.  Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.

[39]  T. Yagi,et al.  Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. , 2003, Developmental cell.

[40]  A. P. Chapman,et al.  PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.

[41]  T. Yamaguchi,et al.  Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization. , 1990, Biochemical and biophysical research communications.

[42]  Sidney Udenfriend,et al.  Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range , 1972, Science.

[43]  M. Filippi,et al.  Multiple sclerosis. , 2018, Nature reviews. Disease primers.

[44]  Yu Zhou,et al.  Building and characterizing antibody-targeted lipidic nanotherapeutics. , 2012, Methods in enzymology.

[45]  B. Frisch,et al.  Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. , 2000, Bioconjugate chemistry.